Filter Results :

Your search for inhibitors returned 502 reports

Sort by


Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight

25 Aug 2016  |  Published by:  KuicK Research
Cancer is ever fastest growing global epidemic and one of the leading causes of death in the developed countries. It was observed that year 2015 alone witnessed more than 10 million new cancer cases. The number of new cancer cases is predicted to rise to 22 million within the next two decades....

$ 2,400.00

Read More

Global Kinase Inhibitors Market Report 2016

14 Aug 2016  |  Published by:  9Dimen Research
2016 Global Kinase Inhibitors Report is a professional and in-depth research report on the world's major regional market conditions of the Kinase Inhibitors industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).The re...

$ 2,850.00

Read More

Global Dye Transfer Inhibitors Market Research Report 2021

10 Aug 2016  |  Published by:  QYResearch
This report studies Dye Transfer Inhibitors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering BASF SE Clariant Intern...

$ 2,900.00

Read More

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Hematology, Rheumatology, Immunology), End User (Hospitals, Clinical Research Laboratories) - Global Forecast to 2021

04 Aug 2016  |  Published by:  MarketsandMarkets
The global plasma fractionation market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 26.07 billion by 2021 from USD 18.84 billion in 2016. Growth in this market is mainly attributed to growing aging population, rising incidences of bleeding and immune disorders, and gr...

$ 5,650.00

Read More

Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Insulin Like Growth Factor (IGF) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor (IGF) Inhibitors. The DelveInsights Report covers the product profiles in various ...

$ 1,250.00

Read More

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Insulin Like Growth Factor 2 (IGF-2) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Insulin Like Growth Factor 2 (IGF-2) Inhibitors. The DelveInsights Report covers the product profiles in ...

$ 1,250.00

Read More

Integrase Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Integrase Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Integrase Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre...

$ 1,250.00

Read More

Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors. The DelveInsights Report covers ...

$ 1,250.00

Read More

Interleukin (IL) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin (IL) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including ...

$ 1,250.00

Read More

Interleukin-1 (IL-1) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-1 (IL-1) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-1 (IL-1) Inhibitors. The DelveInsights Report covers the product profiles in various stages of development in...

$ 1,250.00

Read More

Interleukin-12 (IL-12) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-12 (IL-12) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-12 (IL-12) Inhibitors. The DelveInsights Report covers the product profiles in various stages of developmen...

$ 1,250.00

Read More

Interleukin-13 (IL-13) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-13 (IL-13) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-13 (IL-13) Inhibitors. The DelveInsights Report covers the product profiles in various stages of developmen...

$ 1,250.00

Read More

Interleukin-15 (IL-15) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-15 (IL-15) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-15 (IL-15) Inhibitors. The DelveInsights Report covers the product profiles in various stages of developmen...

$ 1,250.00

Read More

Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-16 (IL-16) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-16 (IL-16) Inhibitors. The DelveInsights Report covers the product profiles in various stages of developmen...

$ 1,250.00

Read More

Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Interleukin-17 (IL-17) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-17 (IL-17) Inhibitors. The DelveInsights Report covers the product profiles in various stages of developmen...

$ 1,250.00

Read More
Total 502 records.